Category: Accesswire

Targeting Initial ‘Stage 1’ Ore Reserves and DFS by 30 June 2026

HIGHLIGHTS

• DFS underway following dual Challenger JORC (2012) Mineral Resources upgrades to 313koz Au^[1]

• Up to 8,000m reverse circulation (RC) drilling to target Challenger ‘Main’, ‘Challenger West’ (CW) open pits, plus open pit targets at ‘Challenger South-Southwest’ (CSSW) and ‘Challenger 3’¹

• DFS objective to establish viable, simplified ‘baseline’ Stage 1 operation to underwrite restart of CGM and maximise Challenger, Tarcoola, Wudinna & Tolmer development optionality

• Discussions underway with credit, minerals trading, and other investment groups interested to finance Stage 1 operations; targeting JORC (2012) Ore Reserves and a DFS by 30 June 2026

ADELAIDE, AU / ACCESS Newswire / February 1, 2026 / Barton Gold Holdings Limited (ASX:BGD)(OTCQB:BGDFF)(FRA:BGD3) (Barton or Company) is pleased to announce the start of JORC upgrade drilling at its South Australian Challenger Gold Project (Challenger), which is adjacent to its wholly-owned Central Gawler Mill (CGM). Kennedy Drilling has been engaged for the program.

Up to 8,000m RC drilling will target conversion of easily accessible mineralisation on existing open pits and other near-surface targets to JORC (2012) ‘Indicated’ categories, for the potential conversion of these materials to JORC (2012) Ore Reserves subject to the completion of an ongoing Definitive Feasibility Study (DFS).

The design concept of the DFS is to commence an initial 3 – 4 year Stage 1 ‘baseline’ operation utilising only historical higher-grade tailings from tailings storage facility 1 (TSF1) and limited, near-surface materials without disturbing Challenger’s historical high-grade underground mine, its mineralisation or its infrastructure access.

The objective of the DFS is to establish relatively low-risk, simplified development plan to restart the CGM, bring Barton to ‘producer’ status, and maximise ‘Stage 1′ development optionality during the next 3 – 10 years. This model also has the benefit of deferring the technical risk and cost of underground operations to a future date, following the de-risking of ‘Stage 1′ operations, and providing further time to optimise development plans.

Reinstatement of the CGM also materially enhances the development optionality of Barton’s several ‘regional enhancement’ assets such as the Tarcoola Gold Project (Tarcoola), the Wudinna Gold Project (Wudinna) and high-grade Tolmer silver prospect (Tolmer) all of which could potentially be processed through the CGM.^[2]

Commenting on Challenger’s Resource upgrade drilling programs, Barton MD Alexander Scanlon said:

“Recent Challenger Resource updates demonstrate considerable on-pit and near-surface gold mineralisation adjacent to our Central Gawler Mill. Our objective is to commence an initial ‘baseline’ operation which minimises both cost and risk, while maximising development optionality for the Challenger underground mine, Tarcoola, Tolmer and Wudinna.

“We have now moved straight to a DFS for reinstatement of the CGM – the region’s only existing gold mill – to enhance this broader optionality and also to capitalise on record gold and silver prices. We are targeting initial ‘Stage 1′ Ore Reserves and a DFS by 30 June 2026, and project financing shortly thereafter. In parallel, we are rapidly advancing our neighbouring large-scale Tunkillia Gold Project, targeting a Mining Lease application by the end of 2026.”

Program background

During September 2025 Barton published a new Challenger JORC (2012) Mineral Resources Estimate (MRE) of 313koz Au (10.6Mt @ 0.92 g/t), with almost all MRE mineralisation located in, on, or adjacent to, existing serviceable open pit and underground development.^[3]

All mineralisation is adjacent to the Company’s Central Gawler Mill (CGM). The updated MRE excludes various lower-grade stockpiles and higher-grade mill residuals (eg. ball mill rejects) which are located on the Run of Mine (ROM) pad. These materials will likely form a component of early mill feed as the hard rock crushing and grinding circuits are recommissioned for the start of Phase 2 (fresh rock) operations.

Authorised by the Board of Directors of Barton Gold Holdings Limited.

For further information, please contact:

Alexander Scanlon Managing Director a.scanlon@bartongold.com.au +61 425 226 649

Jade Cook Company Secretary cosec@bartongold.com.au +61 8 9322 1587

About Barton Gold

Barton Gold is an ASX, OTCQB and Frankfurt Stock Exchange listed Australian gold developer targeting future gold production of 150,000ozpa with 2.2Moz Au & 3.1Moz Ag JORC Mineral Resources (79.9Mt @ 0.87g/t Au), brownfield mines, and 100% ownership of the region’s only gold mill in the renowned Gawler Craton of South Australia.*

Challenger Gold Project 313koz Au + fully permitted Central Gawler Mill (CGM) Tarcoola Gold Project 20koz Au in fully permitted open pit mine near CGM Tolmer discovery grades up to 84g/t Au & 17,600g/t Ag Tunkillia Gold Project 1.6Moz Au & 3.1Moz Ag JORC Mineral Resources Competitive 120kozpa gold & 250kozpa silver project Wudinna Gold Project 279koz Au project located southeast of Tunkillia Significant optionality, adjacent to main highway

Competent Persons Statement & Previously Reported Information

The information in this announcement that relates to the historic Exploration Results and Mineral Resources as listed in the table below is based on, and fairly represents, information and supporting documentation prepared by the Competent Person whose name appears in the same row, who is an employee of or independent consultant to the Company and is a Member or Fellow of the Australasian Institute of Mining and Metallurgy (AusIMM), Australian Institute of Geoscientists (AIG) or a Recognised Professional Organisation (RPO). Each person named in the table below has sufficient experience which is relevant to the style of mineralisation and types of deposits under consideration and to the activity which he has undertaken to quality as a Competent Person as defined in the JORC Code 2012 (JORC).

Activity	Competent Person	Membership	Status
Tarcoola Mineral Resource (Stockpiles)	Dr Andrew Fowler (Consultant)	AusIMM	Member
Tarcoola Mineral Resource (Perseverance Mine)	Mr Ian Taylor (Consultant)	AusIMM	Fellow
Tarcoola Exploration Results (until 15 Nov 2021)	Mr Colin Skidmore (Consultant)	AIG	Member
Tarcoola Exploration Results (after 15 Nov 2021)	Mr Marc Twining (Employee)	AusIMM	Member
Tunkillia Exploration Results (until 15 Nov 2021)	Mr Colin Skidmore (Consultant)	AIG	Member
Tunkillia Exploration Results (after 15 Nov 2021)	Mr Marc Twining (Employee)	AusIMM	Member
Tunkillia Mineral Resource	Mr Ian Taylor (Consultant)	AusIMM	Fellow
Challenger Mineral Resource (above 215mRL)	Mr Ian Taylor (Consultant)	AusIMM	Fellow
Challenger Mineral Resource (below 90mRL)	Mr Dale Sims	AusIMM / AIG	Fellow / Member
Wudinna Mineral Resource (Clarke Deposit)	Ms Justine Tracey	AusIMM	Member
Wudinna Mineral Resource (all other Deposits)	Mrs Christine Standing	AusIMM / AIG	Member / Member

The information relating to historic Exploration Results and Mineral Resources in this announcement is extracted from the Company’s Prospectus dated 14 May 2021 or as otherwise noted, available from the Company’s website at www.bartongold.com.au or on the ASX website www.asx.com.au. The Company confirms that it is not aware of any new information or data that materially affects the Exploration Results and Mineral Resource information included in previous announcements and, in the case of estimates of Mineral Resources, that all material assumptions and technical parameters underpinning the estimates, and any production targets and forecast financial information derived from the production targets, continue to apply and have not materially changed. In accordance with ASX Listing Rule 5.19.2, the Company further confirms that the material assumptions underpinning any production targets and the forecast financial information derived therefrom continue to apply and have not materially changed. The Company confirms that the form and context in which the applicable Competent Persons’ findings are presented have not been materially modified from the previous announcements.

Cautionary Statement Regarding Forward-Looking Information

This document may contain forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “expect”, “target” and “intend” and statements than an event or result “may”, “will”, “should”, “would”, “could”, or “might” occur or be achieved and other similar expressions. Forward-looking information is subject to business, legal and economic risks and uncertainties and other factors that could cause actual results to differ materially from those contained in forward-looking statements. Such factors include, among other things, risks relating to property interests, the global economic climate, commodity prices, sovereign and legal risks, and environmental risks. Forward-looking statements are based upon estimates and opinions at the date the statements are made. Barton undertakes no obligation to update these forward-looking statements for events or circumstances that occur subsequent to such dates or to update or keep current any of the information contained herein. Any estimates or projections as to events that may occur in the future (including projections of revenue, expense, net income and performance) are based upon the best judgment of Barton from information available as of the date of this document. There is no guarantee that any of these estimates or projections will be achieved. Actual results will vary from the projections and such variations may be material. Nothing contained herein is, or shall be relied upon as, a promise or representation as to the past or future. Any reliance placed by the reader on this document, or on any forward-looking statement contained in or referred to in this document will be solely at the readers own risk, and readers are cautioned not to place undue reliance on forward-looking statements due to the inherent uncertainty thereof.

[1] Refer to ASX announcements dated 30 June and 8 / 28 September 2025

[2] Refer to Prospectus and ASX announcements dated 27 March, 15 April, 30 June, 2 / 8 / 25 July, 5 / 6 August and 10 / 23 September 2025

[3] Refer to ASX announcement dated 10 September 2025

* Refer to Barton Prospectus dated 14 May 2021 and ASX announcement dated 8 September 2025. Total Barton JORC (2012) Mineral Resources include 1,049koz Au (39.7Mt @ 0.82 g/t Au) in Indicated category and 1,186koz Au (40.2Mt @ 0.92 g/t Au) in Inferred category, and 3,070koz Ag (34.5Mt @ 2.80 g/t Ag) in Inferred category as a subset of Tunkillia gold JORC (2012) Mineral Resources.

SOURCE: Barton Gold Holdings Limited

View the original press release on ACCESS Newswire

VANCOUVER, BC / ACCESS Newswire / January 30, 2026 / Noram Lithium Corp. (“Noram” or the “Company”) (TSX.V:NRM)(OTCQB:NRVTF)(Frankfurt:N7R) is pleased to announce that it has arranged a fully allocated non-brokered private placement financing (the “Offering”) of up to 10,675,000 units (each, a “Unit”) at a price of $0.10 per Unit for gross proceeds of up to $1,067,500.

Each Unit will consist of one common share and one common share purchase warrant. Each warrant will entitle the holder to purchase one additional common share at a price of $0.15 per share for a period of 36 months from the date of issuance.

The net proceeds of the financing will be used for general working capital, corporate overhead, and exploration and development activities.

Certain insiders of the Company will be participating in the Offering. The issuance of securities to insiders will constitute a related-party transaction within the meaning of TSX Venture Exchange (“TSXV”) Policy 5.9 and Multilateral Instrument 61-101 but is expected to be exempt from the formal valuation and minority shareholder approval requirements.

Finder’s fees may be payable in connection with the Offering

The Company confirms that the Offering will not result in the creation of any new control persons. The offering is subject to acceptance by the TSX Venture Exchange.

For additional information:

Contacts:
In Europe: VP Corporate Development simon.studer@noramlithium.com
Elsewhere: Investor Relations at ir@noramlithiumcorp.com
Website: www.noramlithiumcorp.com

ON BEHALF OF THE BOARD OF DIRECTORS
Sandy MacDougall
Director

About Noram Lithium Corp.

Noram Lithium Corp. (TSXV:NRM)(OTCQB:NRVTF)(Frankfurt:N7R) is focusing on advancing its 100%-owned Zeus Lithium Project located in Clayton Valley, Nevada an emerging lithium hub within the United States. With the upsurge in the electric vehicle and energy storage markets the Company aims to become a key participant in the domestic supply of lithium in the United States. The Company is committed to creating shareholder value through the strategic allocation of capital.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding Forward Looking Information

This news release may contain forward-looking information which is not comprised of historical facts. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release includes statements regarding, among other things, plans for ongoing development of the Zeus Lithium Project. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, regulatory approval processes, results of further exploration work, and availability of capital on terms acceptable to the Company. Although Noram believes that the assumptions used in preparing the forward-looking information in this news release are reasonable, including that all necessary regulatory approvals will be obtained in a timely manner, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Noram disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by applicable securities laws.

SOURCE: Noram Lithium Corp.

View the original press release on ACCESS Newswire

Timeline and Source Materials Now Available at interactivestrength.com/sportstech

AUSTIN, TEXAS / ACCESS Newswire / January 30, 2026 / Interactive Strength Inc. (Nasdaq:TRNR) (“TRNR” or the “Company”), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, and FORME brands, today published a comprehensive summary of the Sportstech transaction, including source materials and SEC filings, on its website.

Trent Ward, Founder and CEO, stated: “We are not sure why Sportstech feels the need to issue press releases targeted towards public-market investors, given they are a private company in Germany, but we can understand it adds confusion to the situation. We hope that Sportstech is attempting to calm its banks and suppliers – given it is undercapitalized and that fulfilling its obligations to TRNR could materially affect its solvency – as opposed to actively trying to impact our shareholders.”

“In the spirit of transparency, and in an effort to simplify a situation that could appear complex, we have consolidated a comprehensive summary of the Sportstech transaction and litigation, along with source materials on our investor website. However, there is nothing complex about paying a loan when it is due.”

“We encourage shareholders to review the materials and draw their own conclusions. Sportstech’s press release this week was very carefully worded, but the facts are straightforward and speak for themselves. Sportstech agrees that they owe us more than $5m. The loan agreements and security documents are public, filed with the SEC, and drafted in compliance with German law. We are actively enforcing our rights.”

The comprehensive Sportstech documentation is available at interactivestrength.com/sportstech.

About Interactive Strength Inc.

Interactive Strength Inc. (Nasdaq:TRNR) has established a leading portfolio of premium fitness brands – Wattbike, CLMBR, and FORME – that combine advanced hardware, smart technology, and immersive content to deliver exceptional training experiences for both commercial and home use. Wattbike offers a range of high-performance indoor bikes that set the global standard in cycling. Known for unmatched accuracy, realistic ride-feel, and advanced performance tracking, Wattbike is trusted by elite athletes, national teams, and fitness enthusiasts around the world. CLMBR produces innovative vertical climbing machines that provide efficient full-body workouts. FORME combines premium smart gyms with live virtual personal training. For more information, visit interactivestrength.com.

Contact:

Investor Relations
ir@interactivestrength.com

Forward-Looking Statements

This press release includes certain statements that are “forward-looking statements” for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements do not relate strictly to historical or current facts and reflect management’s assumptions, views, plans, objectives and projections about the future. These forward-looking statements include, but are not limited to, statements regarding the collectability of the working capital loan, the enforcement of credit remedies, the timing and completion of any public auction, litigation outcomes, expected revenue, and 2026 business development plans. The reader is cautioned not to rely on these forward-looking statements. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of the Company. A further list and descriptions of these risks, uncertainties and other factors can be found in filings with the Securities and Exchange Commission. To the extent permitted under applicable law, the Company assumes no obligation to update any forward-looking statements.

###

SOURCE: Interactive Strength Inc.

View the original press release on ACCESS Newswire

TAMPA, FL / ACCESS Newswire / January 30, 2026 / NeuroEM Therapeutics^®, an award-winning clinical-stage biotechnology research company pioneering the use of radio frequencies to reverse Alzheimer’s disease, announced today the addition of W. Scott Burgin, MD, to its executive team. Burgin, a longtime NeuroEM medical advisor, becomes the company’s first Chief Medical Officer (CMO).

“Dr. Burgin’s appointment marks an exciting and important milestone for NeuroEM. His rare combination of clinical excellence, scientific rigor, and entrepreneurial vision aligns perfectly with our mission to advance transformative neurological care,” said Chuck Papageorgiou, CEO of NeuroEM Therapeutics. “With decades of leadership in stroke neurology, deep expertise in AI‑driven innovation, and a proven track record of translating research into real‑world impact, he brings exactly the kind of forward‑thinking perspective needed to accelerate our next phase of growth.”

Dr. Burgin brings a wealth of expertise across neurology, including clinical care, research, administration, and teaching. His extensive background includes a deep focus on stroke-related AI, biomarkers, and intellectual property development. Throughout his distinguished career, Dr. Burgin has made significant contributions to the medical community, as evidenced by his authorship of more than 100 peer-reviewed articles and his contributions to more than 75 clinical research projects.

In addition to his role at NeuroEM, Dr. Burgin will continue his academic work as a professor of neurology at a nationally recognized academic medical research institution. He previously co-founded two pioneering companies in the Tampa Bay region: one focused on novel neuroprotectant approaches and the other on harnessing the power of AI to assist stroke patients with communication disorders.

“As a medical advisor to NeuroEM, I saw firsthand the depth of its scientific ambition and its unwavering commitment to developing safe, effective, drug-free treatments to restore cognitive health, hope, and dignity to those living with Alzheimer’s and other neurodegenerative diseases,” said Dr. Burgin. “Stepping into the role of Chief Medical Officer is an exciting opportunity to advance that mission even further. I look forward to working alongside this exceptional team to accelerate innovation and bring meaningful neurological solutions to the people who need them most.”

About NeuroEM Therapeutics^®

NeuroEM Therapeutics is leading the way in the development and clinical testing of bioengineered technology to reverse the cognitive decline associated with Alzheimer’s disease and other neurodegenerative conditions. Built on a decade of groundbreaking research conducted at Tampa-based University of South Florida (USF) research facilities, the company received the first Breakthrough Device status from the U.S. Food and Drug Administration (FDA) to treat Alzheimer’s disease. NeuroEM’s continued dedication to cutting-edge research is bringing to market a first-in-class wearable device designed for in-home use to extend healthy longevity using patented Transcranial Electromagnetic Treatment leveraging Radio Frequencies (TEMT-RF) technology. To learn more, visit neuroem.com.

###

Media Contact:

Liz Goar
NPC Creative Services
liz@npccs.com

SOURCE: NeuroEM Therapeutics

View the original press release on ACCESS Newswire

NEW YORK CITY, NEW YORK / ACCESS Newswire / January 30, 2026 / Virtuix Holdings, Inc. (NASDAQ:VTIX), a leader in immersive virtual-reality hardware and location-based VR experiences, today announced it has signed a 12-part, multi-platform media series with New to The Street (NTTS), one of the largest business-focused media platforms combining national television, digital distribution, and iconic out-of-home visibility.

The engagement is designed to deliver sustained, high-impact market exposure for Virtuix through a structured series of long-form executive interviews, guaranteed earned media placements, national television commercials, and iconic billboard campaigns across New York City and the top 10 U.S. markets, with reach expanding monthly.

Unlike one-off media appearances, the 12-part series provides Virtuix with a consistent narrative presence over time, enabling the company to educate investors, partners, and consumers on its technology platform, commercialization strategy, and long-term growth vision across multiple touchpoints.

Program elements include:

• Twelve long-form broadcast and digital interviews

• Earned media distribution across major financial and business outlets

• National :30-second television commercial placements

• Iconic digital billboard exposure across NYC and top U.S. markets

• Coordinated digital and social amplification

“This series structure is built for companies that want continuity, credibility, and repetition in the market – not just a single headline,” said Vince Caruso, Co-Founder and CEO of New to The Street. “Virtuix is advancing immersive technology in a meaningful way, and our platform allows them to communicate that story with depth and consistency across television, digital, and iconic outdoor media.”

The first segments of the series are expected to begin airing in the coming weeks, with additional episodes, commercial placements, and billboard activations rolling out throughout the term of the engagement.

About Virtuix Holdings, Inc.

Virtuix Holdings, Inc. (NASDAQ:VTIX) is a virtual-reality technology company focused on developing immersive hardware and software platforms that enable active, full-body VR experiences for entertainment, fitness, and location-based venues worldwide.

About New to The Street

New to The Street is one of the largest digital business media platforms in its category, with over 4.8 million combined YouTube subscribers across its flagship channels – New to The Street TV (www.youtube.com/@NewtoTheStreetTV) and NewsOut (www.youtube.com/@NewsOutChannel).

With 16+ years of continuous filming and broadcasting, New to The Street has evolved from a long-running television brand into a global, multi-platform media network. The platform delivers weekly programming across the United States, MENA, and Latin America, further amplified by iconic digital billboard placements across New York City and the top 10 U.S. markets, with reach growing month over month.

Media Contact:
Monica Brennan
Communications Lead, New to The Street
Monica@NewtoTheStreet.com

SOURCE: New to The Street

View the original press release on ACCESS Newswire

Funding uncertainty may delay refunds and slow IRS responses during filing season

NEW YORK CITY, NEW YORK / ACCESS Newswire / January 30, 2026 / As lawmakers face renewed funding negotiations, Clear Start Tax warns that another government shutdown could disrupt IRS operations, potentially delaying refunds, slowing correspondence, and limiting taxpayer support services.

During prior shutdowns, IRS staffing levels were reduced, leading to processing backlogs and delayed responses to taxpayer inquiries. Clear Start Tax notes that refunds requiring manual review, identity verification, or credit validation may be especially vulnerable to delays if agency operations are interrupted.

“Even short shutdowns can create long-lasting ripple effects at the IRS,” said a Clear Start Tax spokesperson. “Taxpayers waiting on refunds or trying to resolve notices often feel the impact weeks or months later.”

Clear Start Tax also cautions that IRS collection notices and automated processes may continue during a shutdown, while customer service and resolution timelines slow significantly. This imbalance can leave taxpayers uncertain about deadlines and next steps.

To minimize disruption, Clear Start Tax recommends filing as early as possible, monitoring refund status closely, and addressing any IRS correspondence promptly. Taxpayers with unresolved tax issues or pending refunds may benefit from proactive guidance to avoid complications if government operations are affected.

About Clear Start Tax
Clear Start Tax is a national tax resolution firm that helps individuals and businesses address IRS and state tax issues, including back taxes, penalties, and collection actions. The firm focuses on educating taxpayers about compliance requirements and guiding them through available relief options to achieve lasting financial stability.

Need Help With Back Taxes?
Click the link below:
https://clearstarttax.com/qualifytoday/
(888) 710-3533

SOURCE: Clear Start Tax

View the original press release on ACCESS Newswire

CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / January 30, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that David Berman, M.D., Ph.D. has been appointed as the Company’s Chief Development Officer, beginning March 2, 2026. He will serve on Moderna’s Executive Committee and report to Chief Executive Officer Stéphane Bancel. Dr. Jacqueline Miller will step down as Chief Medical Officer and member of the Executive Committee effective the same date and will remain as a consultant to the Company to assist with the transition.

“David’s leadership experience in oncology and infectious disease will be critical as we continue to invest and drive innovation across Moderna’s pipeline,” said Stéphane Bancel, Chief Executive Officer of Moderna. “I look forward to welcoming David to Moderna’s Executive Committee as Chief Development Officer and partnering with him to advance our portfolio of mRNA medicines. At the same time, I am deeply grateful for Jackie’s leadership and significant contributions over the past five and a half years. She has built a strong foundation and team in infectious disease vaccines at Moderna. The team will continue to drive toward a bright future with three approved vaccines, three more in Phase 3 or filed for approval, and an exciting early pipeline. I wish Jackie all the best in her next chapter.”

Over a two-decade career, Dr. Berman has worked on more than a dozen clinical-stage immunotherapies, including senior leadership roles in developing four oncology biologics. He most recently served as EVP and Head of Research and Development at Immunocore, where he led the development and approval of the first T cell receptor therapeutic. Prior to Immunocore, Dr. Berman served as SVP and Head of AstraZeneca’s Immuno-oncology (IO) franchise, responsible for strategy and execution of a broad IO portfolio. Dr. Berman has also held senior development roles at Bristol-Myers Squibb, including Global Clinical Lead for the first approved IO checkpoint inhibitor and one of the first monoclonal antibodies for multiple myeloma, and served as the head of their early-stage IO portfolio.

“I am honored to take on the role of Chief Development Officer at Moderna, a company at the forefront of transformative medical innovation,” said Dr. Berman. “The strength of Moderna’s mRNA platform and its diverse pipeline position the Company to address some of the most challenging diseases of our time. I look forward to working with the exceptional teams across Moderna to advance our efforts to develop new treatments for cancer, rare and infectious diseases by harnessing the power of the immune system.”

Dr. Berman received his M.D. and Ph.D. from the University of Texas Southwestern Medical School. He trained in pathology at the National Cancer Institute, followed by a fellowship at The Johns Hopkins Hospital.

About Moderna

Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna’s mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.

With a global team and a unique culture, driven by the company’s values and mindsets, Moderna’s mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: Moderna’s product candidates in Phase 3 trials or filed for approval; the potential of Moderna’s platform and pipeline; and Moderna’s efforts to develop new treatments for cancer, rare and infectious diseases. In some cases, forward-looking statements can be identified by terminology such as “will,” “may,” “should,” “could,” “expects,” “intends,” “plans,” “aims,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others, those risks and uncertainties described under the heading “Risk Factors” in Moderna’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (SEC), and in subsequent filings made by Moderna with the SEC, which are available on the SEC’s website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna’s current expectations and speak only as of the date of this press release.

###

Moderna Contacts

Media:
Chris Ridley
Head, Global Media Relations
+1 617-800-3651
Chris.Ridley@modernatx.com

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
+1 617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire